Pharmos (PARS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharmos (PARS)

PARS 2.700

+13.6%

Jan 21 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Richard Huth who wrote (761)	5/9/1999 9:18:00 PM
From: arnie h	Read Replies (1) of 1386

Richard: You have a realistic perspective on PARS. Sales haven't come anyplace close to what company projections were. I hope we'll see some encouragement in the numbers but doubt it or the stock price wouldn't be so low nor would there be 1 million shares being sold short. Short sellers have always been on the money in PARS. HU 211 is a nice research program but until there is some tangible sign of endorsement by a partner, it remains that regardless of the optimism shown on the thread. We'll hope for the best but PARS shows little sign of being less than a long term, speculative investment much as are a large number of other small biotech companies. Arnie

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next